Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21)

The purpose of this grant is to advance our understanding of the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and risk factors for infection to inform efforts to prevent KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases in populations living with HIV or at high risk of developing HIV.

Funding: 275,000 per year

Duration: 2 years 

Research Authority due date: 9.7.18

LOI (encouraged) due date: 16.7.18

Full porposal due date: 16.8.18